Thrombosomes® in Bleeding Thrombocytopenic Patients

Clinical trial NCT03394755 · COMPLETED

Trial details

NCT number: NCT03394755
Sponsor: Cellphire Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Thrombocytopenia Hematologic Diseases Bone Marrow Aplasia

Start date: 2018-03-19
Primary completion: 2019-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.